CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus

Journal of Clinical Investigation

Volumn 127, Issue 4, 2017, Pages 1271-1283

  Faridi, Mohd Hafeez ^a   Khan, Samia Q ^a   Zhao, Wenpu ^b   Lee, Ha Won ^a   Altintas, Mehmet M ^a   Zhang, Kun ^c   Kumar, Vinay ^d   Armstrong, Andrew R ^a   Carmona Rivera, Carmelo ^b   Dorschner, Jessica M ^e   Schnaith, Abigail M ^e   Li, Xiaobo ^a   Ghodke Puranik, Yogita ^e   Moore, Erica ^b   Purmalek, Monica ^b   Irizarry Caro, Jorge ^b   Zhang, Tingting ^f   Day, Rachael ^g   Stoub, Darren ^g   Hoffmann, Victoria ^h   Khaliqdina, Shehryar Jehangir ^a   Bhargava, Prachal ^a   Santander, Ana M ⁱ   Torroella Kouri, Marta ⁱ   Issac, Biju ⁱ   Cimbaluk, David J ^j   Zloza, Andrew ^k   Prabhakar, Rajeev ^f   Deep, Shashank ^d   Jolly, Meenakshi ^j   Koh, Kwi Hye ^a   Reichner, Jonathan S ^l   Bradshaw, Elizabeth M ^m   Chen, Jianfeng ^c   Moita, Luis F ⁿ   Yuen, Peter S ^o   Tsai, Wanxia Li ^b   Singh, Bhupinder ^p   Reiser, Jochen ^a   Nath, Swapan K ^p   Niewold, Timothy B ^e   Vazquez Padron, Roberto I ^q   Kaplan, Mariana J ^b   Gupta, Vineet ^a   more..

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^d INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^e MAYO CLINIC   (United States)

^f University of Miami   (United States)

^g DORDT COLLEGE   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ UNIVERSITY OF MIAMI   (United States)

^j RUSH MEDICAL COLLEGE   (United States)

^k ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^l RHODE ISLAND HOSPITAL   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^o NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^p OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^q UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD11B ANTIGEN; INTEGRIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; FOXO3 PROTEIN, HUMAN; FOXO3 PROTEIN, MOUSE; IRF3 PROTEIN, HUMAN; IRF3 PROTEIN, MOUSE; IRF7 PROTEIN, HUMAN; IRF7 PROTEIN, MOUSE; ITGAM PROTEIN, HUMAN; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MOUSE; MOUSE MODEL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; WILD TYPE; ANIMAL; GENETICS; IMMUNOLOGY; MACROPHAGE; MALE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY;

ANIMALS; ANTIGENS, CD11B; FEMALE; FORKHEAD BOX PROTEIN O3; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MALE; MICE; MICE, INBRED MRL LPR; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; TOLL-LIKE RECEPTORS;

EID: 85018666210     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI88442     Document Type: Article

References (78)

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110-2121.
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783-801.
3. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007;8(6):492-502.
4. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40(2):204-210.
5. Hom G, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358(9):900-909.
6. Nath SK, et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet. 2008;40(2):152-154.
7. Zhou Y, et al. Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils. Arthritis Rheum. 2013;65(11):2907-2916.
8. Kim-Howard X, et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis. 2010;69(7):1329-1332.
9. Fagerholm SC, MacPherson M, James MJ, Sevier-Guy C, Lau CS. The CD11b-integrin (ITGAM) and systemic lupus erythematosus. Lupus. 2013;22(7):657-663.
10. MacPherson M, Lek HS, Prescott A, Fagerholm SC. A systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis. J Biol Chem. 2011;286(19):17303-17310.
11. Rhodes B, et al. The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Ann Rheum Dis. 2012;71(12):2028-2034.
12. Maiti AK, et al. Combined protein-and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM. Hum Mol Genet. 2014;23(15):4161-4176.
13. Rosetti F, et al. A lupus-associated Mac-1 variant has defects in integrin allostery and interaction with ligands under force [published online ahead of print March 11, 2015]. Cell Rep. https://doi. org/10.1016/j.celrep.2015.02.037.
14. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol. 2010;11(8):734-742.
15. Ding C, et al. Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance. Nat Commun. 2013;4:2813.
16. Tang T, et al. A role for Mac-1 (CDiIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med. 1997;186(11):1853-1863.
17. Cao C, Gao Y, Li Y, Antalis TM, Castellino FJ, Zhang L. The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. J Clin Invest. 2010;120(6):1971-1980.
18. Liu JR, Han X, Soriano SG, Yuki K. The role of macrophage 1 antigen in polymicrobial sepsis. Shock. 2014;42(6):532-539.
19. Kevil CG, et al. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease. Am J Pathol. 2004;165(2):609-616.
20. Rosetti F, et al. Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J Immunol. 2012;189(7):3714-3723.
21. Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med. 2002;8(4):373-378.
22. Rosetti F, Mayadas TN. The many faces of Mac-1 in autoimmune disease. Immunol Rev. 2016;269(1):175-193.
23. Wang L, et al. Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity. 2010;32(4):518-530.
24. Huynh L, Wang L, Shi C, Park-Min KH, Ivashkiv LB. ITAM-coupled receptors inhibit IFNAR signaling and alter macrophage responses to TLR4 and Listeria monocytogenes. J Immunol. 2012;188(7):3447-3457.
25. Fan ST, Edgington TS. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest. 1991;87(1):50-57.
26. Whitlock BB, Gardai S, Fadok V, Bratton D, Henson PM. Differential roles for (M)(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms. J Cell Biol. 2000;151(6):1305-1320.
27. Rezzonico R, Imbert V, Chicheportiche R, Dayer JM. Ligation of CD11b and CD11c ?(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1?) and MIP-1? production in primary human monocytes through a pathway dependent on nuclear factor-?B. Blood. 2001;97(10):2932-2940.
28. Guha M, Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem. 2002;277(35):32124-32132.
29. Rubel C, Gómez S, Fernández GC, Isturiz MA, Caamaño J, Palermo MS. Fibrinogen-CD11b/ CD18 interaction activates the NF-?B pathway and delays apoptosis in human neutrophils. Eur J Immunol. 2003;33(5):1429-1438.
30. Kettritz R, Choi M, Rolle S, Wellner M, Luft FC. Integrins and cytokines activate nuclear transcription factor-?B in human neutrophils. J Biol Chem. 2004;279(4):2657-2665.
31. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285(5430):1028-1032.
32. Yee NK, Hamerman JA. ?(2) integrins inhibit TLR responses by regulating NF-?B pathway and p38 MAPK activation. Eur J Immunol. 2013;43(3):779-792.
33. Means TK, Luster AD. Integrins limit the Toll. Nat Immunol. 2010;11(8):691-693.
34. Whitlock BB, Gardai S, Fadok V, Bratton D, Henson PM. Differential roles for ?(M)?(2) integrin clustering or activation in the control of apoptosis via regulation of akt and ERK survival mechanisms. J Cell Biol. 2000;151(6):1305-1320.
35. Maiguel D, et al. Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal. 2011;4(189):ra57.
36. Faridi MH, et al. Identification of novel agonists of the integrin CD11b/CD18. Bioorg Med Chem Lett. 2009;19(24):6902-6906.
37. Salas A, Shimaoka M, Phan U, Kim M, Springer TA. Transition from rolling to firm adhesion can be mimicked by extension of integrin ?L?2 in an intermediate affinity state. J Biol Chem. 2006;281(16):10876-10882.
38. Faridi MH, Altintas MM, Gomez C, Duque JC, Vazquez-Padron RI, Gupta V. Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta. 2013;1830(6):3696-3710.
39. Doi K, Leelahavanichkul A, Yuen PS, Star RA. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest. 2009;119(10):2868-2878.
40. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-851.
41. Teijaro JR, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell. 2011;146(6):980-991.
42. Rutigliano JA, et al. Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells. J Virol. 2014;88(3):1636-1651.
43. Bouvier NM, Lowen AC. Animal models for influenza virus pathogenesis and transmission. Viruses. 2010;2(8):1530-1563.
44. Litvak V, et al. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature. 2012;490(7420):421-425.
45. Lin R, Heylbroeck C, Pitha PM, Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol. 1998;18(5):2986-2996.
46. Laird MH, et al. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol. 2009;85(6):966-977.
47. Doyle S, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 2002;17(3):251-263.
48. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816-825.
49. Lee JC, et al. Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell. 2013;155(1):57-69.
50. Andrews BS, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978;148(5):1198-1215.
51. Pérez de Lema G, et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol. 2001;12(7):1369-1382.
52. Kanauchi H, Furukawa F, Imamura S. Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol. 1991;96(4):478-483.
53. Knight JS, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis. 2015;74(12):2199-2206.
54. Furumoto Y, et al. Tofacitinib ameliorates murine lupus and its associated vascular dysfunction. Arthritis Rheum. 2017;69(1):148-160.
55. Ozgor L, Brandl C, Shock A, Nitschke L. Epratuzumab modulates B-cell signaling without affecting B-cell numbers or B-cell functions in a mouse model with humanized CD22. Eur J Immunol. 2016;46(9):2260-2272.
56. Thacker SG, et al. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis. Arthritis Rheum. 2012;64(9):2975-2985.
57. Chen D, et al. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. Circulation. 1999;100(8):849-854.
58. Semmrich M, et al. Importance of integrin LFA-1 deactivation for the generation of immune responses. J Exp Med. 2005;201(12):1987-1998.
59. Park EJ, et al. Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes. Blood. 2010;115(8):1572-1581.
60. Park EJ, et al. Aberrant activation of integrin alpha4beta7 suppresses lymphocyte migration to the gut. J Clin Invest. 2007;117(9):2526-2538.
61. O'Gorman WE, et al. Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus. J Allergy Clin Immunol. 2015;136(5):1326-1336.
62. Ehirchiou D, Xiong Y, Xu G, Chen W, Shi Y, Zhang L. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J Exp Med. 2007;204(7):1519-1524.
63. Ivashkiv LB. How ITAMs inhibit signaling. Sci Signal. 2011;4(169):pe20.
64. Dransfield I, Hogg N. Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. EMBO J. 1989;8(12):3759-3765.
65. Gupta V, et al. The beta-tail domain (?TD) regulates physiologic ligand binding to integrin CD11b/CD18. Blood. 2007;109(8):3513-3520.
66. Ortlepp S, Stephens PE, Hogg N, Figdor CG, Robinson MK. Antibodies that activate ?2 integrins can generate different ligand binding states. Eur J Immunol. 1995;25(3):637-643.
67. Honda K, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434(7034):772-777.
68. Hua J, Kirou K, Lee C, Crow MK. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 2006;54(6):1906-1916.
69. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007;8(6):492-502.
70. Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
71. Yuen PS, Dunn SR, Miyaji T, Yasuda H, Sharma K, Star RA. A simplified method for HPLC determination of creatinine in mouse serum. Am J Physiol Renal Physiol. 2004;286(6):F1116-F1119.
72. Figueiredo N, et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity. 2013;39(5):874-884.
73. Fuss IJ, Kanof ME, Smith PD, Zola H. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol. 2009;Chapter 7:Unit 7.1.
74. Lacey DC, et al. Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol. 2012;188(11):5752-5765.
75. Mia S, Warnecke A, Zhang XM, Malmström V, Harris RA. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-? yields a dominant immunosuppressive phenotype. Scand J Immunol. 2014;79(5):305-314.
76. Chevrier N, et al. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell. 2011;147(4):853-867.
77. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. Curr Protoc Immunol. 2008;Chapter 14:Unit 14.1.
78. Kariuki SN, et al. Genetic analysis of the pathogenic molecular sub-phenotype interferon-? identifies multiple novel loci involved in systemic lupus erythematosus. Genes Immun. 2015;16(1):15-23.